News

Article

I Can’t Believe I’m Here: A Poem About Breast Cancer

Author(s):

Joyce Wigler

I had been diagnosed with triple-negative breast cancer just three months after my mother passed away from the same disease.

A well-worn, padded reclining chair

I can’t believe I’m here

A cozy, extra soft blanket tucked around my toes

I can’t believe I’m here

A squishy, fresh-smelling pillow behind my head

I can’t believe I’m here

A rolling snack wagon with my favorite cookies

I can’t believe I’m here

A gentle hand helping me up

I can’t believe I’m here

A friendly neighbor sharing her story

I can’t believe I’m here

A turkey sandwich and a cool drink

I can’t believe I’m here

My first chemo treatment

I CAN’T BELIEVE I’M HERE!

I wrote this poem after receiving chemo at Danbury hospital in 2005. I had been diagnosed with triple-negative breast cancer just three months after my mother passed away from the same disease. Although the care during chemo was exemplary and I was treated royally it was still chemo. Thankfully I am cancer free now and living my best life.


This post was written and submitted by Joyce Wigler. The article reflects the views of Wigler and not of CURE®. This is also not supposed to be intended as medical advice.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Image of a woman with light shoulder-length hair, wearing rectangular glasses.
Related Content
Illustration of a woman with red hair.
March 5th 2025

Becoming a Better Version of Me After Breast Cancer

Bonnie Annis
A revelation has given me perspective for the New Year, inspiring me to embrace change, set new goals and upgrade myself to a better version in 2025.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Illustration of woman with brown hair.
March 4th 2025

Breast Cancer And Depending On The Kindness Of Strangers

Laura Yeager
I reflect on my unexpected bond with a neighbor during my breast cancer treatment, finding comfort in his company when I needed someone to talk to.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Camizestrant combo had a statistically significant and clinically meaningful improvement in PFS in advanced breast cancer; © Pixel-Shot - stock.adobe.com
March 1st 2025

Camizestrant Combo Improves Progression Time in HR+/HER2– Breast Cancer

Ryan Scott
Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in HR+/HER2– advanced breast cancer.
Illustration of woman with black hair.
February 27th 2025

My Cousin and I Journey Through Breast, Lung, Pancreatic and Prostate Cancer

Sue McCarthy
After realizing that a stronger support system would have helped me emotionally and spiritually in my cancer journey, I committed myself to being there for my cousin.